MedPath

App-supported Vestibular Rehabilitation (RCT)

Not Applicable
Recruiting
Conditions
Vestibular Abnormality
Vestibular Diseases
Vestibular Disorder
Interventions
Device: Vestibular rehabilitation phone application
Registration Number
NCT06350669
Lead Sponsor
University of Haifa
Brief Summary

A randomized controlled trial to assess the efficacy of an app-assisted vestibular rehabilitation in increasing adherence to VR and treatment outcomes

Detailed Description

Vestibular Rehabilitation (VR) home exercises, prescribed by physiotherapists, are the main treatment for vestibular dysfunction. However, reports by clinicians indicate that patients do not fully comply with the treatment. Advances in technology and tele-rehabilitation have the potential to facilitate adherence to home exercise, if they are designed to overcome the barriers for practice. We plan to continue and expand our previous feasibility study with the vestibular phone app, in order to examine the effects of an app-assisted VR program on adherence and treatment outcomes. The patients in this study will be randomly assigned to the intervention (app-assisted vestibular rehabilitation) or the control group (standard vestibular rehabilitation, no app).

Tests and measurements for both groups will be done at three time points:

1. Preliminary assessment session (Session 1)- An initial assessment test on the first visit;

2. Secondary assessment session (Session 2)- After 5-6 weeks;

3. Follow-up evaluation session (Session 3)- One month after the secondary assessment session.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Individuals aged 18 and over
  • Diagnosis with any vestibular disorder that requires a vestibular rehabilitation exercise program
  • Physical and cognitive ability to perform vestibular physiotherapy
Exclusion Criteria
  • A physical disability that does not allow for the performance of vestibular physiotherapy
  • A diagnosis of a central vestibular disorder caused by structural damage to the brain
  • Individuals who are not qualified to give informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
App-assisted vestibular rehabilitationVestibular rehabilitation phone applicationThe patients in this group will undergo standard vestibular rehabilitation treatment with the addition of a phone app that support the treatment program, e.g., providing reminders for exercise, documentation of exercise performance, communication with the therapist, etc.
Primary Outcome Measures
NameTimeMethod
Adherence measuresAt the end of Cycle 1 (each cycle is 4-6 weeks)

Quantitative data on adherence to home exercise will be extracted from users' phone application database (intervention group) or from records in a diary / logs (control group)

Timed up and go (TUG)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

Assesses balance, walking ability and also used as a screening test for the risk of falls by assessing the function of the lower limbs. The individual is required to get up from sitting on a chair, walk 3 meter forward at a normal pace, turn around and return to a sitting position. The examiner times this sequence

Secondary Outcome Measures
NameTimeMethod
Vestibular functions- physical examinationAt the the beginning of Cycle 1 (each cycle is 4-6 weeks)

The routine assessment of vestibular functions, with fixation and without fixation. These functions include observation of gait, posture, gaze / detection of spontaneous nystagmus and it's characteristics, Vestibulo-Ocular reflex (VOR), head impulse test, head shaking nystagmus, dix-hallpike test, supine roll test and dynamic visual acuity (DVA)

Oculomotor functions- physical examinationAt the the beginning of Cycle 1 (each cycle is 4-6 weeks)

The routine assessment of oculomotor functions: Saccades, Smooth-Pursuit, Vestibulo-Ocular Reflex cancellation (VORc) test, Convergence, single cover and cover-uncover test

Activities-specific Balance Confidence Scale (ABC)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

A questionnaire that measures the patient's level of balance confidence in performing daily activities

Dynamic Gait Index (DGI)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

Assesses patient's ability to maintain balance while walking in the presence of external demands

Video Head Impulse Test (vHIT)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

A test to evaluate the angular VOR and the function of the superior and inferior vestibular nerves

Cognitive reserve index questionnaire (CRIQ)By the end of Cycle 1 (each cycle is 4-6 weeks)

A questionnaire for assessing the degree of cognitive reserve. Cognitive reserve describes the resilience of the brain to damage, and is used to interpret individual differences in susceptibility to cognitive impairment in the presence of brain changes associated with age or disease.

10-Meters Walk Test (10MWT)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

Estimates walking speed in meters per second of a short distance (10-meter walking distance)

2-Minute Walk Test (2MWT)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

Measures the distance the subject can walk in two minutes, aiming to assess endurance, functional mobility and gait

Demographics and medical history intakeAt the beginning of Cycle 1 (each cycle is 4-6 weeks)

Characteristics of patients

Dynamic Visual Acuity (DVA)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

Tests visual acuity during head movement, which rely on the behavior of the Vestibulo-ocular reflex (VOR)

Suppression Head Impulse Test (SHIMP)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

To provide the examiner with complementary information about peripheral vestibular function. This is a sensitive indicator of residual vestibular function as well as the usual VOR (Vestibulo-ocular reflex) gain measure

Visual Analogue Scale (VAS)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

Subjective ranking of the severity of symptoms of dizziness and nausea in sitting position, standing and walking

Dizziness Handicap Inventory (DHI)At the beginning of Cycle 1, the end of Cycle 1 and the end of Cycle 2 (each cycle is 4-6 weeks)

The Hebrew version of the Dizziness Handicap Inventory (DHI) questionnaire

Exercise difficulty levels and symptoms severityAt the end of Cycle 1 (each cycle is 4-6 weeks)

Quantitative data exercise difficulty levels and symptoms severity will be extracted from users' phone application database

Trial Locations

Locations (1)

Sheba Medical Center

🇮🇱

Ramat Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath